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Abstract
Mitochondrial function, in particular complex 1 of the electron transport chain (ETC), has
been shown to decrease during normal ageing and in neurodegenerative disease. How-
ever, there is some debate concerning which area of the brain has the greatest complex 1
activity. It is important to identify the pattern of activity in order to be able to gauge the effect
of age or disease related changes. We determined complex 1 activity spectrophotometri-
cally in the cortex, brainstem and cerebellum of middle aged mice (70–71 weeks), a cere-
bellar ataxic neurodegeneration model (pcd5J) and young wild type controls. We share our
updated protocol on the measurements of complex1 activity and find that mitochondrial frac-
tions isolated from frozen tissues can be measured for robust activity. We show that com-
plex 1 activity is clearly highest in the cortex when compared with brainstem and cerebellum
(p<0.003). Cerebellum and brainstem mitochondria exhibit similar levels of complex 1 activ-
ity in wild type brains. In the aged brain we see similar levels of complex 1 activity in all
three-brain regions. The specific activity of complex 1 measured in the aged cortex is signifi-
cantly decreased when compared with controls (p<0.0001). Both the cerebellum and brain-
stem mitochondria also show significantly reduced activity with ageing (p<0.05). The
mouse model of ataxia predictably has a lower complex 1 activity in the cerebellum, and
although reductions are measured in the cortex and brain stem, the remaining activity is
higher than in the aged brains. We present clear evidence that complex 1 activity decreases
across the brain with age and much more specifically in the cerebellum of the pcd5j mouse.
Mitochondrial impairment can be a region specific phenomenon in disease, but in ageing
appears to affect the entire brain, abolishing the pattern of higher activity in cortical regions.
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Introduction
Complex 1 is the largest of the five enzyme supercomplexes in the mitochondrial electron
transport chain. Though it performs the major first step of the oxidative phosphorylation path-
way it is still not completely understood partly due to the number of its sub-units and their
potential interactions[1]. Interruption of the activity of complex 1 either by toxins such as rote-
none, drugs like 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) or due to genetic dis-
orders such as Leigh’s Syndrome or Leber hereditary optic neuropathy has debilitating
consequences[2][3].
Many studies support the mitochondrial theory of ageing, in particular the hypothesised
decreased functionality of the ETC: complex 1 is often cited as the most likely site of an ETC
impairment [4] [5], [6], [7], [8]. Complex 1 is thought to be a site of impairment due to more
of the subunits being encoded by mitochondrial rather than nuclear DNA. Mitochondrial
DNA due to its proximity to reactive oxygen species produced by this organelle is proposed to
be more susceptible to oxidative damage[9] [7], [10]. Complex 1 activity has been shown to
decrease with age in various tissues when experimentally determined, most notably in rat brain
and heart, where a strong positive correlation was demonstrated between a decreased complex
1 functionality and an increase in ROS production [8].
Decreases in complex 1 have also been demonstrated in diseases more frequently encoun-
tered in older age such as neurodegeneration; in particular Parkinson’s disease (PD) [11], [12].
Complex 1 began to be implicated in the aetiology of certain neurodegenerative disorders fol-
lowing an accidental intake of a complex 1 inhibitor– 1-methyl-4-phenyl-1,2,3,6-tetrahydro-
pyridine (MPTP) by a group of drug addicts, who developed with symptoms unable to be
differentiated from true Parkinson’s disease [13]. Complex 1 inhibitors such as rotenone pro-
duce similar pathology in rats providing excellent models to study neurodegenerative processes
[12].
Though we already know that complex 1 decreases in the brain during ageing and neurode-
generation we set out to measure directly which gross anatomical region displays the greatest
activity or undergoes greatest changes in aged or disease brains. Previous studies of rat brain
suggest the greatest complex 1 activity exists in the cortex and cerebellum but others suggest
that no differences are displayed, or that the cerebellum in fact has lowest measured activity
[6], [14], [15].
The aim of this study was to establish and compare the levels of complex 1 activity in the
three major brain compartments. Our study differentiates between the effects of ageing and of
neurodegeneration by studying a mouse model that undergoes the neurodegenerative process
at a young age[16].
To investigate complex 1 activity changes in neurodegeneration a mouse model was used;
the Purkinje cell degeneration mouse (pcd5J). The pcd5J mouse is a neurological autosomal
recessive phenotype. Within 3 weeks of birth pcd5J mice begin to lose their cerebellar Purkinje
cells, by 4 weeks of age the animals have developed pronounced gait ataxia [17], [18], [19]. The
pcd5J mouse model is caused by a mutation in the Nna1/CCP1 gene [20]. Nna1 encoded pro-
teins have been shown to be localised in mitochondria, and a loss of these proteins or their
function results in mitochondrial dysfunction, including complex I activity deficits [21].
Despite an increased interest in mitochondrial function in ageing and neurological disease
we found that the overall levels of complex 1 activity are not known in the three major com-
partments of the mammalian brain. In disease this information can be highly relevant since
early in the process it may be that circuits in a non-diseased region of the brain can compensate
for neurodegeneration. In normal ageing we wanted to know whether mitochondrial dysfunc-
tion measured via complex 1 activity affects the entire brain or one compartment more
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specifically. We show here that there are indeed significant differences in complex 1 activity
between the brain compartments measured. The activity values change significantly with age
and in neurodegeneration.
Materials and Methods
Animals were bred and housed in accordance with strict Home Office stipulated conditions.
The overall programme of work (in respect to the original UK Home Office Project Licence
application) is reviewed by the Animal Welfare and Ethical Review Body at the University of
Nottingham and then scrutinised by the UK Home Office Inspectorate before approval by the
Secretary of State. Individual study protocols link to the overarching Home Office Project
Licence and are made available to the Named Animal Care and Welfare Officer, the Named
Veterinary Surgeon (both are members of the AWERB), the animal care staff and the research
group. The Project Licence Number for the breeding and maintenance of this genetically
altered line of mice is PPL 40/3576. The mice are typically group housed and maintained
within solid floor cages containing bedding and nesting material with additional environmen-
tal enrichment including chew blocks and hiding tubes. Cages are Individually Ventilated Cage
Units within a barrier SPF unit to maintain bio-security. Animals are checked daily by a com-
petent and trained animal technician. Any animal giving cause for concern such as subdued
behaviour, staring coat, loss of weight or loss of condition will be humanely killed using a
Home Office approved Schedule 1 method of killing.
Mouse tissues
Animals were divided into 3 groups; Group 1: 21 young wild type mice varying in age from 10–
18 weeks days, group 2: seven Purkinje cell degeneration mice (pcd5J) varying in age from 10–
13 weeks days, group 3: six old mice aged 70–71 weeks (C57BL/6J) (Table 1). Animals were
killed by cervical dislocation in accordance with the humane killing of animals under schedule
1 to the Animals (Scientific Procedures) Act 1986.
Mitochondrial isolation
Whole mouse brain was divided into three sections; cortex, cerebellum and brainstem. Samples
were placed in GentleMACS C tubes with mitochondrial extraction buffer (consisting of 50
mM Tris-HCl ph7.4, 100 mM KCl, 1.5 mMMgCl2, 1 mM EGTA, 50 mMHEPES and 100 mM
sucrose; all sourced from Sigma) and homogenised using a GentleMACS Dissociator (Miltenyi
Biotec). The resulting homogenates were spun at 4°C in an Eppendorf Model 5417R Microcen-
trifuge (Fisher Scientific); firstly at 850 x g for 10 minutes, then the supernatant obtained was
centrifuged separately at 1000 x g for 10 minutes to yield a nuclear pellet and a final spin at
10000 x g for 30 minutes to produce the mitochondrial pellet; the remaining supernatant con-
tained the cytosolic fraction. Additional mitochondrial extraction buffer was added to the
mitochondrial pellet and re-spun to obtain a purer fraction of isolated mitochondria. All pro-
tein extractions were stored at -80°C.
Table 1. The numbers and age ranges of animals analysed.
Animal type Number collected Age range of animals
Wild type 17 10–18 weeks
Aged 6 70–71 weeks
pcd5J 7 10–13 weeks
doi:10.1371/journal.pone.0157405.t001
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Mitochondrial extractions from the different brain regions of three wild type mice were pre-
pared fresh, straight after sample collection. The remaining samples were all frozen at -80°C
following collection, they were thawed later to extract mitochondrial fractions. This difference
in sample preparation was used to help determine whether extracting mitochondria from fro-
zen samples rather than fresh impacts upon the integrity of the mitochondria and the enzyme
activity of the sample.
Protein assay
The protein concentrations of the samples were determined using the Bradford Assay—Sigma
[22]. Bovine serum albumin (BSA- Fisher Scientific) standards of known protein concentration
varying from 0 to 2 mg/ml were added to Bradford reagent in disposable cuvettes (Fisher Scien-
tific) and the absorbance was measured spectrophotometrically at 595nm in a Thermo Scien-
tific Spectrometer Helios Episilon (Fisher Scientific). The absorbance of the known protein
standards were plotted using a linear regression. The mitochondrial fractions were diluted 1 μl
in 100 μl Tris Buffer and added to Bradford reagent before the absorbance was measured. The
absorbance was plotted against the BSA standard curve to determine the estimated protein
concentration (mg/ml).
Protein determination for the complex 1 assay
The complex 1 spectrophotometric assay used in this study was based upon the protocol by
Janssen and colleagues [23], with modifications incorporated from the protocol published by
Spinazzi [24]. Janssen did not specify a protein weight to load into the assay, instead recom-
mending a volume of mitochondrial suspension (2.5 μl -> 20 μl), whereas Spinazzi stated a
minimum weight of 20 μg -> 50 μg mitochondrial protein. The mitochondrial pellets extracted
from some cerebellum and brainstem samples were small, so a protein concentration of 30 μg
at the lower end of the suggested range by Spinazzi was selected to ensure the volume of sample
required in the assay did not exceed sample availability. In order to measure the whole enzyme
activity that could be detected from each sample by this assay, freeze-thaw cycles were incorpo-
rated. Two additional freeze-thaw cycles were integrated into the protocol prior to the assay;
therefore prior to loading the 30 μg, the sample of mitochondrial extraction had been through
five freeze thaw cycles.
Complex 1 Assay
Mitochondrial fractions underwent five freeze-thaw cycles to disrupt the mitochondrial mem-
branes. The reaction cuvette contained 920 μl from a 100 ml complex 1 buffer stock (containing
25 mmol/L monobasic potassium phosphate, 120 μl of 50 mmol/L dichlorophenolindophenol
(DCIP), 100 μl of 1mmol/L Antimycin A, 400 μl of 17.5 mmol/L Decylubiquinone, made up to
100 ml with RO water), 50 μl of 70 g/L fatty acid free BSA and 30 μg of mitochondrial sample
(all reagents sourced from Sigma). The volume of mitochondrial extract required to load 30ug
was previously determined by Bradford assay as described.
The cuvette volume absorbance was recorded at 600nm and allowed to equilibrate at room
temp for 1 minute before the initiation of the reaction by the addition of 20 μl of 10 mmol/L
stock of NADH (Sigma) after which the absorbance was recorded every 30s for 2.5 minutes.
The complex 1 inhibitor rotenone (Sigma) dissolved in dimethyl sulfoxide at a concentration
of 40 mmol/L was added to the reaction volume and mixed vigorously before the absorbance
was recorded every 30s for a further 3 minutes.
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Calculating Enzymatic Activity
Enzyme activity was calculated as described by Spinazzi and colleagues [24]. The following
equation was used to calculate enzyme activity;
Enzyme activity ðnmol=min=mgÞ
¼ ðDAbsorbance=min 1; 000Þ=½ðextinction coefficient of DCIP
 volume of sample used in 1mlÞ  ðsample protein concentration in mg=mlÞ
Extinction coefficient of DCIP: 19.1 mM-1cm-1 (Janssen et al. 2007).
Overall activity reaction rate was determined by calculating enzyme activity following the
addition of NADH. The rotenone resistant activity rate was determined by readings following
the addition of the inhibitor rotenone. Following rotenone addition the reaction cuvette was
allowed to equilibrate for one minute after which changes in absorbance were recorded again.
Specific Complex 1 enzyme activity was calculated by subtracting the rotenone resistant activ-
ity from the total enzyme activity.
Data distribution
The nature of the distribution of data for Complex 1 activity within each brain region; cortex,
cerebellum and brainstem was determined by use of R (R Core Team (2014). R: A language
and environment for statistical computing. R Foundation for Statistical Computing, Vienna,
Austria http://www.R-project.org/). The data that were found to be normally distributed were
plotted as histograms using parametric methods.
Statistical analysis
Within each brain region the activity of the various sample types; wild type, pcd5J and old were
presented as a mean average alongside calculated standard deviation and standard error mean.
Noted differences amongst the various sample types within each brain region, and between the
different regions were assessed for significance. Unpaired t-test’s with Welch’s correction and
one-way ANOVA tests were formed on the results using GraphPad Prism version 6 for Win-
dows, GraphPad Software, San Diego California USA, www.graphpad.com.
Results
The activity of complex 1 was highest in all the brain regions from wild
type mitochondria compared with the aged and pcd5J brain mitochondria
The wild type brain from mice aged 10–18 weeks were used for the ‘young brain mitochondria’
control group. The pcd5J mouse represents a model for neurodegeneration. In all brain regions
the mitochondria from wild type animals displayed a greater complex 1 activity in comparison
to the activity in the aged animals and neurodegeneration model (Fig 1D–1F).
Complex 1 activity of wild type mice is highest in the cortex mitochondria
Complex 1 activity of the cortex, cerebellum and brainstem of wild type mouse brain produced
significant differences (one way ANOVA p value = 0.0015) (Table 2). Activity was measured to
be the greatest in the cortex; significantly higher than cerebellum (p value = 0.0026) and the
brainstem samples (p value = 0.0028). No significant difference in Complex 1 activity was mea-
sured between wild type cerebellum and brainstem samples (p value = 0.7765) (Table 2).
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Fig 1. A) The cortex displays significantly higher complex 1 activity in wild typemitochondria compared to other brain regions. Complex 1 activity
was measured spectrophotometrically in the cortex, cerebellum and brainstemmitochondria of wild type mice aged 10–18 weeks. Complex 1 activity is
significantly higher in the cortex compared to the activity in the cerebellum and brainstem of wild type animals. The cerebellum and brainstemmitochondria in
wild type animals exhibit similar levels of complex 1 activity. (Cortex n = 11, cerebellum n = 16, brainstem n = 15). B) In aged animals, complex 1 activity is
similar in all three-brain regions. Complex 1 activity was measured spectrophotometrically in the cortex, cerebellum and brainstemmitochondria of aged
mice (70–71 weeks old). The reduction in complex 1 activity in the brain with ageing is not region-specific suggesting that the decrease in activity affects the
entire brain. (Cortex n = 6, cerebellum n = 6, brainstem n = 6). C) Complex 1 activity is significantly reduced in pcd5J cerebellummitochondria.
Complex 1 activity was measured spectrophotometrically in the cortex, cerebellum and brainstemmitochondria from a neurodegeneration mouse model,
pcd5J, aged 10–13 weeks. Complex 1 activity in the cerebellummitochondria is significantly lower than the activity in the cortex and brainstemmitochondria.
(Cortex n = 6, cerebellum n = 7, brainstem n = 6). D) Complex 1 activity is significantly reduced in the aged cortex mitochondria compared with wild
type and pcd5J cortex mitochondria. Complex 1 activity was significantly reduced in the pcd5J cortex compared to the wild type cortex mitochondria.
However, the aged cortex mitochondria displayed the lowest complex 1 activity. (Wild type n = 11, aged n = 6, pcd5J n = 6). E) Similar levels of complex 1
activity are observed in cerebellar mitochondria from aged and pcd5J animals. Both the aged and pcd5Jmitochondria exhibit reduced levels of complex
1 activity in the cerebellum compared with the wild type cerebellummitochondria. (Wild type n = 16, aged n = 6, pcd5J n = 7). F) Significantly reduced levels
of complex 1 activity are observed in the aged and pcd5J brainstemmitochondria compared to wild type brainstemmitochondria. (Wild type n = 15,
aged n = 6, pcd5J n = 6). All assays contained 30mg/ml mitochondrial protein. Replicates were carried out from brain tissue isolated from individual animals.
Columns display mean activity ± SEM. * = p<0.05, ** = p<0.03, *** = p <0.02, **** = p <0.01 two-tailed t-test with Welch’s correction. ns = no significant
difference. Refer to tables 2 and 3 for p values.
doi:10.1371/journal.pone.0157405.g001
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Complex 1 activity of pcd5Jmouse mitochondria is highest in the cortex
Complex 1 activity measured in the pcd5J mouse brain identified significant differences
between the cortex, cerebellum and brainstem mitochondria (one way ANOVA p value =
<0.0001) (Fig 1C and Table 2). Greatest complex 1 activity is in the cortex, and the recorded
mean activity is significantly higher than the cerebellum (p value =<0.0001) and the brainstem
samples (p value = 0.0003). In contrast with the wild type samples, a significant difference in
measured complex 1 activity existed between pcd5J cerebellum and brainstem samples (p
value = 0.017). This would be expected for a model of cerebellar degeneration.
Overall complex 1 activity is similar across all three-brain regions in aged
mitochondria
Complex 1 activity measured in the old mice brains produced no significant difference between
the cortex, cerebellum and brainstem samples (one way ANOVA p value = 0.72) (Fig 1B and
Table 2). Complex 1 activity is slightly higher in the cortex, but not significantly greater than
the recorded activity in the brainstem samples (p value = 0.29) and that of cerebellum mito-
chondria (p value = 0.65). No significant difference in activity was recorded between the old
cerebellum and brainstem samples (p value = 0.82).
Complex 1 activity decreases with age and neurodegeneration
In all three brain regions (cortex, cerebellum and brainstem) the recorded complex 1 activity is
significantly decreased in the old mice and pcd5J when compared with wild type mice. The
greatest age related decrease is observed in the cortex (p value =<0.0001)) when comparing
wild type to aged mitochondria. Similarly in the pcd5J mouse mitochondria complex 1 activity
is significantly decreased compared to the control, the greatest decrease is observed within the
cerebellum (p value = 0.0001) (Fig 1 and Table 3).
Table 2. Comparisons of complex 1 between wild-type, aged and pcd5Jmouse brain mitochondria.
Animal Analysis between Statistical test p value
Wild type (10–18 weeks) Cortex/Cerebellum Unpaired t-test with Welch's
correction
0.0026*
Wild type (10–18 weeks) Cortex/Brainstem Unpaired t-test with Welch's
correction
0.0028*
Wild type (10–18 weeks) Cerebellum/Brainstem Unpaired t-test with Welch's
correction
0.78
Wild type (10–18 weeks) Cortex/Cerebellum/Brainstem One-way ANOVA 0.0015*
Aged (70 weeks) Cortex/Cerebellum Unpaired t-test with Welch's
correction
0.65
Aged (70 weeks) Cortex/Brainstem Unpaired t-test with Welch's
correction
0.29
Aged (70 weeks) Cerebellum/Brainstem Unpaired t-test with Welch's
correction
0.82
Aged (70 weeks) Cortex/Cerebellum/Brainstem One-way ANOVA 0.72
pcd5J (10–13 weeks) Cortex/Cerebellum Unpaired t-test with Welch's
correction
< 0.0001*
pcd5J (10–13 weeks) Cortex/Brainstem Unpaired t-test with Welch's
correction
0.0003*
pcd5J (10–13 weeks) Cerebellum/Brainstem Unpaired t-test with Welch's
correction
0.017*
pcd5J (10–13 weeks) Cortex/Cerebellum/Brainstem One-way ANOVA <0.0001*
doi:10.1371/journal.pone.0157405.t002
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Complex 1 activity was measured to be greater in mitochondria
extracted from frozen rather than fresh tissues
Measured complex 1 activity of wild type cortex and brainstem mitochondria extracted from
frozen tissue samples is significantly higher than mitochondria extracted from similar fresh
samples (Fig 2). There isn’t a significant difference in complex 1 activity measured in mito-
chondria extracted from frozen wild type cerebellum compared to fresh (Table 4).
Discussion
Our study aimed to reveal baseline complex 1 activity in the three major compartments of
mammalian brain. We looked to see whether there are detectable region specific changes at
this level, in response to ageing or neurodegeneration.
We find significant differences in complex 1 activity when comparing distinct regions of the
brain. In all sample types; wild type, pcd5J and old, the cortex was measured to have a higher
mean complex 1 activity compared to the cerebellum and brainstem. This contradicts previous
work in the rat citing the cerebellum as the area of greatest complex 1 activity [6]. The observed
increase in activity in this brain region could be caused by a greater amount of complex 1 pres-
ent in the mitochondria in the cortex. Complex 1 is composed of many subunits, and some
genes encoding for these subunits, for example the Ndufa10 gene are seen to have a higher
expression in the cortex when compared to the cerebellum and pons (S1 Fig).
We found complex 1 activity to be significantly diminished in cortex, cerebellum and brain-
stem mitochondria isolated from aged mice when compared to the wild type mice used as a
young control group. A number of studies have previously reported similar findings [6], [7],
[25], [26], [27]. This is contradictory to previous research that has shown no significant decline
in complex 1 activity in brain tissues [28]. The significant decline in measured complex 1
Table 3. Complex 1 activity comparison of cortex, cerebellum, and brainstemmitochondria.
Brain region Analysis between Statistical test p value
Cortex Wild type/Aged Unpaired t-test with Welch's
correction
<0.0001*
Cortex Wild typed/pcd5J Unpaired t-test with Welch's
correction
0.035*
Cortex Aged/pcd5J Unpaired t-test with Welch's
correction
0.0003*
Cortex Wild type/Aged/pcd5J One-way ANOVA 0.0001*
Cerebellum Wild type/Aged Unpaired t-test with Welch's
correction
0.0197*
Cerebellum Wild type/pcd5J Unpaired t-test with Welch's
correction
0.0001*
Cerebellum Aged/pcd5J Unpaired t-test with Welch's
correction
0.69
Cerebellum Wild type/Aged/pcd5J One-way ANOVA 0.0025*
Brainstem Wild type/Aged Unpaired t-test with Welch's
correction
0.0060*
Brainstem Wild typed/pcd5J Unpaired t-test with Welch's
correction
0.027*
Brainstem Aged/pcd5J Unpaired t-test with Welch's
correction
0.084
Brainstem Wild type/Aged/pcd5J One-way ANOVA 0.054
doi:10.1371/journal.pone.0157405.t003
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enzymatic activity in the brain could be caused by a reduction in mitochondrial functionality
with age; supporting the hypothesis of the ‘mitochondrial theory of ageing’ [29].
The greatest decrease in complex 1 activity with age was measured in the cortex when com-
paring wild type and old brain samples. This finding is contradicted by previous work that
noted a 30% decline in the complex 1 activity of the cortex; much lower than the 50–60% in the
brainstem [6]. Our findings suggest that complex 1 in the cortex undergoes a greater decrease
Fig 2. Mitochondria extracted from frozen cortex and brainstem tissue recorded greater complex 1 activity.Mitochondria were
extracted from freshly collected and frozen murine brain tissue samples (cortex, cerebellum and brainstem). All assays contained 30mg/
ml mitochondrial protein. The activity of complex 1 is found to be significantly greater in mitochondria from frozen cortex and brainstem
tissues in comparison to mitochondria extracted from fresh tissue. n = 9 from 3 separate brains (cortex n = 3, cerebellum n = 3, brainstem
n = 3). Columns display mean activity ± SEM. * = P <0.05 two-tailed t-test with Welch’s correction. ns = no significant difference.
doi:10.1371/journal.pone.0157405.g002
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in functionality in ageing brain. Many of the 45 subunits making up complex 1, are encoded
for by mitochondrial DNA, which may be more susceptible to oxidative damage. One of the
mitochondrial DNA subunits of complex 1 is encoded for by the mitochondrial encoded
NADH:ubiquinone oxidoreductase core subunit 3 gene (MT-ND3). In situ hybridisation (ISH)
of mouse cortex has been shown to display a higher density of MT-ND3 expression in contrast
to the cerebellum; potentially supporting the hypothesis of a greater target mass of complex 1
in the cortex in comparison to other brain regions (supplementary data)[30].
The cortex has substantially decreased functionality with age compared with the cerebellum
and brainstem. The hind brain regions appear to age similarly; exhibiting no significant differ-
ence between the brain regions of the wild type control and the old samples. However the simi-
lar pattern of complex 1 activity change seen in ageing of the cerebellum and brainstem is not
reflected in the neurodegeneration model. The complex 1 activity measured in the pcd5J cere-
bellum is significantly lower than the brainstem, suggesting that complex 1 function is affected
to a greater extent in the cerebellum which is where the neurodegeneration occurs in this
model. The cerebellum has been shown to contain significantly lower mitochondrial DNA
copy numbers in comparison to other brain regions (Fuke et al 2011). Mutations to mitochon-
drial DNA may have a greater effect in regions of the brain that are low in mitochondrial DNA
copy number. The reduced function of complex 1 in the cerebellum is unsurprising considering
the neurodegeneration model used. The pcd5J phenotype is characterised by a dramatic and
rapid loss of Purkinje cells in the cerebellum [16]. Purkinje cells contain mitochondria, so
destruction of the cells will be correlated to a loss of mitochondria from the cerebellum. A loss
of mitochondria equates to a loss of complex 1. It could be suggested that this loss of mitochon-
dria from the cerebellum is sufficient enough to cause a significant decrease of complex 1 activ-
ity. However, this would infer that the majority of complex 1 activity in the cerebellum is
housed in the Purkinje cells which make up a small percent of the overall cerebellar volume.
An unexpected result of this study was that complex 1 activity was measured to be greater in
mitochondria extracted from samples which were frozen upon collection, rather than in the
mitochondria extracted from fresh samples. Previous studies have recommended the use of
fresh mitochondrial extractions in order to maximise enzyme activity [31], [32]. A possible
explanation is that the additional initial freeze-thaw cycle the ‘frozen samples’ underwent had
the beneficial effect of releasing an increased number of mitochondria from within the cell
membrane [33].
Conclusions
The cortex was determined as the brain region exhibiting the greatest mitochondrial complex 1
activity. We show that complex 1 activity decreased with age, which supports the mitochon-
drial theory of ageing and promotes further research into a mitochondrial, in particular com-
plex 1, role in the aetiology of ageing.
The pcd5J mouse exhibited a decrease in complex 1 activity compared to the control group.
Our findings support previously published research exhibiting a diminished complex 1 activity
Table 4. Comparison of complex 1 activity in mitochondria isolated from either freshly collected tis-
sue or frozen tissue.
Brain region from wild type mouse brain Unpaired t-test with Welch's correction p value
Cortex fresh/frozen 0.0378*
Cerebellum fresh/frozen 0.5272
Brainstem fresh/frozen 0.0137*
doi:10.1371/journal.pone.0157405.t004
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in the pcd5J mouse model [21]. The significant decrease of activity in the cerebellum demon-
strates that the loss of Purkinje cells has a negative impact upon the mitochondrial function of
the cerebellum as a whole. Throughout this study we have measured and compared equal
quantities of mitochondrial protein from each region of the brain. Therefore our conclusion
must be that the activity we measure is not per brain region but per mitochondrial unit. This
needs to be taken into consideration when analysing brain tissues for mitochondrial content,
in that increased numbers of mitochondria may not correspond proportionately to increased
activity and ATP production.
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Supporting Information
S1 Fig. A) The gene expression of NDUFA10 (NADH:ubiquinone oxidoreductase subunit
a10) is higher in the cortex than the cerebellum and pons. NDUFA10 gene expression in
mouse (images and data from Allen Mouse Brain Atlas). Raw expression value of NDUFA10 of
13.78 in the cortex (I), 8.37 in the cerebellum (II) and 9.00 in the pons (III). B) The gene
expression of NADH oxidoreductase core subunit 3 (MT-ND3) is higher in the cortex than
in the cerebellum. MT-ND3 gene expression in mouse in situ hybridisation from the Allen
Mouse Brain Atlas. Raw expression value in cortex (I) 14.91, lower expression of 10.67 in cere-
bellum [30]. Website: 2015 Allen Institute for Brain Science. Allen Mouse Brain Atlas [Inter-
net]. Available: http://mouse.brain-map.org. NDUFA10: http://mouse.brain-map.org/gene/
show/43116 and MT-ND3: http://mouse.brain-map.org/gene/show/17485.
(TIF)
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